A research group led by Associate Professor Tetsuya Muramoto from the Faculty of Science, Toho University, has established a ...
The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the ...
Matthew Herper covers medical innovation — both its promise and its perils. A CRISPR-based gene editing therapy dramatically reduced levels of low-density lipoprotein, often called “bad cholesterol,” ...
I was born in Washington, DC, in 1964, the oldest of three sisters, but the place that truly formed me as a scientist was Hilo, on the Big Island of Hawaii. Growing up there, far from the mainland ...
A caffeine-triggered switch that turns CRISPR gene editing on and off inside cells could one day improve cancer therapy.
We preselected all newsletters you had before unsubscribing.
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments ...
Phase 1 ATLAS trial to evaluate TK-6302 in patients with advanced PRAME-positive solid tumors authorized for initiation SAN ...
While caffeine is usually associated with energy and focus, scientists are now exploring a very different use for it. New ...